Literature DB >> 16460845

Use of available outer membrane vesicle vaccines to control serogroup B meningococcal outbreaks.

Muhamed-Kheir Taha, Maria Leticia Zarantonelli, Jean-Michel Alonso, Lisbeth Meyer Naess, Johan Holst, Berit Feiring, Einar Rosenqvist.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16460845     DOI： 10.1016/j.vaccine.2005.12.059

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  8 in total

1.  A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice.

Authors:  Rolando Pajon; Carolyn M Buckwalter; Kay O Johswich; Scott D Gray-Owen; Dan M Granoff
Journal:  Vaccine       Date:  2015-02-04       Impact factor: 3.641

2.  Liposome-like Nanostructures for Drug Delivery.

Authors:  Weiwei Gao; Che-Ming J Hu; Ronnie H Fang; Liangfang Zhang
Journal:  J Mater Chem B       Date:  2013-12-28       Impact factor: 6.331

3.  Novel blocking human IgG directed against the pentapeptide repeat motifs of Neisseria meningitidis Lip/H.8 and Laz lipoproteins.

Authors:  Tathagat Dutta Ray; Lisa A Lewis; Sunita Gulati; Peter A Rice; Sanjay Ram
Journal:  J Immunol       Date:  2011-03-14       Impact factor: 5.422

4.  Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2.

Authors:  Oliver Koeberling; Serena Giuntini; Anja Seubert; Dan M Granoff
Journal:  Clin Vaccine Immunol       Date:  2008-12-24

5.  Meningococcal carriage during a clonal meningococcal B outbreak in France.

Authors:  V Delbos; L Lemée; J Bénichou; G Berthelot; M-K Taha; F Caron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-06-02       Impact factor: 3.267

6.  Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa.

Authors:  P T Beernink; D A Caugant; J A Welsch; O Koeberling; D M Granoff
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

7.  Recombinant PorA, the major outer membrane protein of Campylobacter jejuni, provides heterologous protection in an adult mouse intestinal colonization model.

Authors:  Anjum Islam; Raj Raghupathy; M John Albert
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

Review 8.  Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future.

Authors:  Johan Holst; Philipp Oster; Richard Arnold; Michael V Tatley; Lisbeth M Næss; Ingeborg S Aaberge; Yvonne Galloway; Anne McNicholas; Jane O'Hallahan; Einar Rosenqvist; Steven Black
Journal:  Hum Vaccin Immunother       Date:  2013-03-07       Impact factor: 3.452
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.